Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole. [electronic resource]
Producer: 20190705Description: 784-798 p. digitalISSN:- 1520-5010
- Adverse Outcome Pathways
- Biological Assay
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Fatty Liver -- chemically induced
- Fungicides, Industrial -- toxicity
- Gene Expression
- HEK293 Cells
- Hepatocytes -- drug effects
- Humans
- Mitochondria, Liver -- drug effects
- Models, Biological
- Polymerase Chain Reaction
- Receptors, Cytoplasmic and Nuclear -- metabolism
- Risk Assessment
- Triazoles -- toxicity
- Triglycerides -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.